Stallion India Fluorochemicals Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
- April 28, 2026
- Posted by: Neeraj Pandey
- Category: News
Stallion India Fluorochemicals (NSE: STALLION) is set to announce its Q4 FY26 financial results for the quarter and full year ended March 31, 2026. The board of directors is scheduled to meet on May 2026 (Expected) to approve the audited financial statements and consider a recommendation for a final dividend for FY26. Investors tracking the Stallion India Fluorochemicals Q4 results 2026 date, earnings estimates, and analyst outlook will find all the key details covered in this article.
With Stallion India Fluorochemicals trading at a current market price of Rs 148 against a 52-week high of Rs 265 and a 52-week low of Rs 112, the Q4 FY26 results will be a pivotal data point for investors deciding on their position. Analyst estimates for Q4 FY26 revenue stand at Rs 198 to 218 Cr, with PAT expectations of Rs 24 to 30 Cr and margin projections of 13 to 15%. Get free investment predictions and live Q4 result alerts on Univest.
This article covers the Stallion India Fluorochemicals Q4 results 2026 date, detailed earnings estimates, five key performance factors, five risks to monitor, analyst ratings and price targets, and answers to the most commonly searched investor questions about Stallion India Fluorochemicals ahead of its Q4 FY26 results.
Stallion India Fluorochemicals Q4 Results 2026 Date
Get free investment predictions on Univest.
Stallion India Fluorochemicals has scheduled its Q4 FY26 results for May 2026 (Expected). The board of directors will meet to approve the audited consolidated financial statements for the quarter and full year ended March 31, 2026. The trading window for designated employees is closed until 48 hours after the results announcement, as per SEBI regulations. Here is how the broader Q4 FY26 earnings calendar looks for select Indian companies in April and May 2026:
| Company | Q4 FY26 Results Date |
|---|---|
| TCS | April 9, 2026 (Declared) |
| Stallion India Fluorochemicals | May 2026 (Expected) |
Source: BSE/NSE exchange filings, April 2026. Expected dates may change. Verify before relying.
Why This Quarter Matters for Stallion India Fluorochemicals
Stallion India Fluorochemicals enters Q4 FY26 with expectations of meaningful year-on-year improvement in its core Specialty Chemicals Fluorine business. Q4 is typically a seasonally important quarter as companies execute on year-end targets, government orders pick up, and annual dividend recommendations are made. For Stallion India Fluorochemicals specifically, Q4 FY26 matters because it sets the baseline for FY27 estimates and determines full-year FY26 performance.
Every quarterly result tells a story, but Stallion India Fluorochemicals’s Q4 FY26 print will be watched closely because it sets the baseline for FY27 estimates, determines full-year FY26 performance, and provides the first clear read on whether the business momentum is accelerating or decelerating. Management guidance on margins, volumes, and capital allocation will be just as important as the headline PAT number. Screen Stallion India Fluorochemicals fundamentals on the Univest Screener.
Stallion India Fluorochemicals Q4 FY26 Earnings Estimates
Access premium SEBI-registered research on Univest.
Brokerages including MOFSL, YES Securities, JM Financial, and others have published their Q4 FY26 preview estimates for Stallion India Fluorochemicals. The consensus expects Rs 198 to 218 Cr in revenue for Q4 FY26, compared to Rs 185 Cr in Q3 FY26. Profit after tax (PAT) is estimated at Rs 24 to 30 Cr, with margin expectations of 13 to 15%.
| Metric | Q3 FY26 Actual | Q4 FY26 Estimate | YoY Trend |
|---|---|---|---|
| Revenue | Rs 185 Cr | Rs 198 to 218 Cr | Sequential growth expected |
| PAT (Net Profit) | Rs 22 Cr | Rs 24 to 30 Cr | Improvement anticipated |
| EBITDA Margin | 11.9% | 13 to 15% | Stable to marginal improvement |
| Revenue Growth Driver | Core business execution | Seasonal uptick plus order execution | Positive |
| Dividend Expectation | As per FY26 policy | Final dividend possible | Board discretion |
Stallion India Fluorochemicals enters Q4 FY26 with expectations of Rs 198 to 218 Cr in revenue driven by execution on existing orders and seasonal demand pickup. Management commentary on the pipeline and deal wins will set the direction for FY27 estimates. Screen Stallion India Fluorochemicals fundamentals on the Univest Screener.
5 Key Factors That Will Drive Stallion India Fluorochemicals Q4 FY26 Performance
1. Revenue Execution and Order Book Conversion
Stallion India Fluorochemicals enters Q4 FY26 with a focus on executing on its existing order book and converting pipeline into recognised revenue. Q4 is seasonally important for the Specialty Chemicals Fluorine sector and the ability to deliver on committed orders will be the first performance test. Analysts expect Rs 198 to 218 Cr in revenue for Q4 FY26. A beat here would signal improving execution capability and set a strong base for FY27 guidance. Track live revenue updates on the Univest Screener.
2. Margin Recovery and Cost Control
Q4 FY26 margin expectations are 13 to 15% versus 11.9% in Q3 FY26. Input cost trends, employee expense efficiency, and pricing power in key markets will collectively determine whether Stallion India Fluorochemicals can sustain or improve on Q3 margins. Any margin beat here would be a meaningful positive catalyst for the stock and for FY27 earnings visibility.
3. Final Dividend and Capital Allocation Signals
Q4 board meetings are typically when companies announce their final dividend for the fiscal year. Stallion India Fluorochemicals’s capital allocation stance, including whether it maintains, increases, or skips the final dividend, will signal management confidence in the business outlook. A higher-than-expected dividend payout would be a positive surprise for income-focused investors tracking the Stallion India Fluorochemicals Q4 results 2026.
4. FY27 Management Guidance
Investors should monitor revenue versus Rs 198 to 218 Cr and PAT versus Rs 24 to 30 Cr as the two primary watchpoints. If FY27 guidance falls below Street expectations, the stock may decline even if Q4 numbers are in line. Forward guidance carries more weight than the reported quarter in the current environment. Get SEBI-registered research on Univest.
5. Sector Tailwinds and Macro Environment
The Specialty Chemicals Fluorine sector in India is benefiting from structural demand drivers including government capex, domestic consumption recovery, and a supportive policy environment. Stallion India Fluorochemicals’s ability to translate these sector tailwinds into quarterly earnings growth will be closely watched by institutional investors. The RBI rate cut cycle that commenced in 2026 has also reduced borrowing costs across the sector, providing a further boost to profitability.
5 Risks to Watch in Stallion India Fluorochemicals Q4 FY26
1. Revenue Miss Risk
If revenue comes in below the Rs 198 to 218 Cr estimate range, it would signal execution challenges in the Specialty Chemicals Fluorine business. A miss at the revenue line typically triggers a cascading impact on PAT and margin, amplifying the negative reaction in the stock price.
2. FII Selling Pressure
FIIs sold Rs 22,000 crore in Indian equities in a single week following the US tariff announcement in early April 2026. Continued selling would create headwinds for Stallion India Fluorochemicals regardless of company-specific fundamentals. With global risk appetite still cautious, institutional positioning remains a key external risk for the stock heading into Q4 results.
3. Margin Compression Risk
Input cost inflation, wage increases, and pricing pressure in key markets could compress Stallion India Fluorochemicals’s margins below the 13 to 15% estimate. Any margin miss combined with a revenue miss creates a double negative that typically leads to sharp post-results corrections. Monitor margin trends on the Univest Screener.
4. Regulatory and Policy Risks
The Specialty Chemicals Fluorine sector faces evolving regulatory frameworks. Policy changes that increase compliance costs or alter competitive dynamics could affect Stallion India Fluorochemicals’s profitability beyond current consensus models. Any negative regulatory development announced alongside the Q4 results could weigh on investor sentiment.
5. Weak FY27 Guidance Risk
Even if Q4 FY26 numbers come in line with estimates, a below-consensus FY27 guidance from management would be the single biggest negative catalyst. The market prices stocks on forward earnings, and a guidance cut would compress the valuation multiple applied to Stallion India Fluorochemicals’s earnings, pushing the stock lower despite an acceptable reported quarter.
Stallion India Fluorochemicals Share Price and Analyst Ratings
Stallion India Fluorochemicals is trading at Rs 148 as of April 2026, against a 52-week high of Rs 265 and 52-week low of Rs 112. The stock has a market capitalisation of approximately Rs 680 Cr. Download the Univest iOS App or Univest Android App for live Stallion India Fluorochemicals Q4 result alerts and SEBI-registered research.
| Brokerage | Rating | Target Price | Key Thesis |
|---|---|---|---|
| MOFSL | Buy | Rs 192 | Stallion India Fluorochemicals Specialty Chemicals Fluorine sector growth outlook FY27 |
| YES Securities | Buy | Rs 185 | Stallion India Fluorochemicals Specialty Chemicals Fluorine sector growth outlook FY27 |
| Emkay | Buy | Rs 178 | Stallion India Fluorochemicals Specialty Chemicals Fluorine sector growth outlook FY27 |
Conclusion
Stallion India Fluorochemicals Q4 FY26 results on May 2026 (Expected) will be a key event for investors monitoring the Specialty Chemicals Fluorine sector. Analysts project PAT of Rs 24 to 30 Cr and revenue of Rs 198 to 218 Cr. FY27 guidance will be the most critical post-results catalyst alongside the headline Q4 numbers. For more Q4 FY26 previews, visit Univest Blogs.
Disclaimer: Investment in the share market is subject to risk. This article is for informational and educational purposes only and does not constitute investment advice. All financial data and analyst estimates are sourced from publicly available information including NSE/BSE filings and company investor relations pages. Verify all numbers before investing. Consult a SEBI-registered advisor before making investment decisions.
Frequently Asked Questions
What is the Stallion India Fluorochemicals Q4 results 2026 date?
The Stallion India Fluorochemicals Q4 results 2026 date is May 2026 (Expected). The board of directors will meet on this date to approve the audited financial results for the quarter and full year ended March 31, 2026.
What is the Stallion India Fluorochemicals Q4 FY26 PAT estimate?
Analyst consensus estimates Stallion India Fluorochemicals Q4 FY26 PAT at Rs 24 to 30 Cr, based on revenue of Rs 198 to 218 Cr and margin of 13 to 15%. The actual number will be declared on May 2026 (Expected).
What is Stallion India Fluorochemicals’s share price ahead of Q4 results?
Stallion India Fluorochemicals is trading at Rs 148 ahead of Q4 FY26 results. The 52-week high is Rs 265 and the 52-week low is Rs 112. The market cap is approximately Rs 680 Cr. Track live price on the Univest Screener.
Will Stallion India Fluorochemicals declare a dividend in Q4 2026?
The Stallion India Fluorochemicals board may consider a final dividend for FY26 at its Q4 results board meeting on May 2026 (Expected). Dividend decisions are at board discretion and depend on the company’s profitability and cash flow position for the full year. Track dividend announcements on NSE or the Univest Screener.
Which analysts have a Buy rating on Stallion India Fluorochemicals?
MOFSL (Target: Rs 192), YES Securities (Target: Rs 185), Emkay (Target: Rs 178). Analyst ratings and target prices change frequently. Always verify the latest ratings on the Univest Screener.
What were Stallion India Fluorochemicals Q3 FY26 results?
Stallion India Fluorochemicals reported revenue of Rs 185 Cr and PAT of Rs 22 Cr in Q3 FY26, with an operating margin of 11.9%. The Q4 FY26 results on May 2026 (Expected) will provide the next quarterly update. Get detailed financial analysis on Univest.
When does TCS announce Q4 results 2026?
TCS declared Q4 FY26 results on April 9, 2026. Find the full TCS Q4 FY26 analysis on Univest Blogs.
Is Stallion India Fluorochemicals a good investment ahead of Q4 results?
Whether Stallion India Fluorochemicals is a good investment ahead of Q4 FY26 results depends on your investment horizon and risk appetite. At Rs 148, the stock is trading at a discount to its 52-week high of Rs 265. Analyst consensus targets range from Rs 178 to Rs 192. Always consult a SEBI-registered financial advisor before making any investment decision. Get free research on Univest.
Recent Article
Mangalam Cement Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
NESCO Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
Madhurima Plantation Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
Moser Baer India Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
Mopeds Industries Q4 Results 2026: Date, Revenue, PAT and Analyst Outlook
